Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2014
03/05/2014EP2703394A1 Novel 3-hydroxyisothiazole 1-oxide derivative
03/05/2014EP2702030A1 Compositions and methods
03/05/2014EP2701744A1 Combination therapy
03/05/2014EP2701701A1 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
03/05/2014CN103619355A Apoptosis-inducing agent
03/05/2014CN103619354A Antipruritic agent
03/05/2014CN103611163A Anticancer medicine composition containing interferon alpha-conjugate
03/05/2014CN103611161A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
03/05/2014CN103611160A Method for extracting, separating and purifying glucosidase inhibitor
03/05/2014CN103610734A Application of mucuna birdwoodiana extract in preparation of drugs for treating leukemia
03/05/2014CN103610649A Medicament microsphere and preparation method thereof
03/05/2014CN103610643A Preparation method of lipidosome applicable to water-soluble anthraquinone medicament
03/05/2014CN103040768B Powder mixing technology for compound antibiotic
03/05/2014CN102755309B Application of cajanin to preparation of medicament for treating or preventing caput femoris necrosis
03/05/2014CN102380101B Pholcodine-containing compound pharmaceutical preparation for treating cold
03/05/2014CN102242080B Method for treating or diagnosing heart failure or tendency of heart failure or improving functions of myocardial cells by miR-24 (MicroRNA-24)
03/05/2014CN102228690B Application of antifolic in constructing mouse model with neural tube defects (NTDs)
03/05/2014CN101998859B Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics
03/05/2014CN101701006B Phenethanolamine derivatives for treatment of respiratory diseases
03/05/2014CN101330929B Inhibitor of transplanted islet dysfunction in islet transplantation
03/04/2014US8666680 Recombinant soluble FC receptors
03/04/2014US8664224 External preparation for athlete's foot treatment
03/04/2014US8663654 Polysaccharide vaccine for staphylococcal infections
03/04/2014US8663652 Regeneration of endogenous myocardial tissue
03/04/2014US8663646 P53 peptide vaccine
03/04/2014US8663155 Transdermal drug delivery devices having coated microprotrusions
03/04/2014CA2565188C Compounds and compositions for delivering active agents
03/04/2014CA2278854C Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes
02/2014
02/27/2014WO2014031901A1 Methods of use for monomethyl fumarate and prodrugs thereof
02/27/2014WO2014031769A2 Treatment of diseases associated with inflammation
02/27/2014WO2014030049A2 Compositions comprising a single variable domain and camostat mesylate (cm)
02/27/2014WO2014029848A1 Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling
02/27/2014WO2014029669A1 Combinations (catechins and methotrexate) for use in the treatment of melanomas
02/27/2014WO2014029333A1 Substituted oxazolidinone compound and pharmaceutical composition comprising the compound and use thereof
02/27/2014WO2014008374A3 Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents
02/27/2014WO2013171661A3 Adjuvant formulations and methods
02/27/2014US20140057993 Prophylaxis and Treatment of Enteropathogenic Bacterial Infection
02/27/2014US20140057985 Estrogen receptor ligands and methods of use thereof
02/27/2014US20140057982 Retinoids and use thereof
02/27/2014US20140057977 Induction of Arteriogenesis
02/27/2014US20140057959 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
02/27/2014US20140057937 Antagonists of chemokine receptors
02/27/2014US20140057924 Bivalent inhibitors of iap proteins and therapeutic methods using the same
02/27/2014US20140057915 Kinase inhibitors
02/27/2014US20140057914 Heterocyclic modulators of hif activity for treatment of disease
02/27/2014US20140057910 Heterocyclic aspartyl protease inhibitors
02/27/2014US20140057905 Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis
02/27/2014US20140057904 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway
02/27/2014US20140057902 Diazepinone derivatives
02/27/2014US20140057898 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
02/27/2014US20140057896 Pyridone and aza-pyridone compounds and methods of use
02/27/2014US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
02/27/2014US20140057883 Treatment of crohn's disease with laquinimod
02/27/2014US20140057882 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
02/27/2014US20140057881 Composition for the Treatment of Skin Conditions
02/27/2014US20140057880 Antcin derivatives in combination with anti-cancer drugs in the treatment and/or prevention of tumors
02/27/2014US20140057873 Nitric oxide releasing amino acid ester compound, composition and method of use
02/27/2014US20140057872 Dosage forms of risedronate
02/27/2014US20140057871 Cyclic amide derivative
02/27/2014US20140057870 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors
02/27/2014US20140057866 Phosphoramidate derivatives of 5 - fluoro - 2` - deoxyuridine for use in the treatment of cancer
02/27/2014US20140057864 Compositions and methods for treating or preventing a retrovirus infection
02/27/2014US20140057862 Formulations of histone deacetylase inhibitor and uses therof
02/27/2014US20140057846 Products and methods using soy peptides to lower total and ldl cholesterol levels
02/27/2014US20140057844 Chemical entities and therapeutic uses thereof
02/27/2014US20140057838 Osteoblast-expressed lipocalin 2 regulates glucose metabolism
02/27/2014US20140057836 Hcv ns3 protease inhibitors
02/27/2014US20140057001 Methods of decreasing sebum production in the skin
02/27/2014US20140056999 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
02/27/2014US20140056990 Composition for the treatment of migraine headaches and methods thereof
02/27/2014US20140056988 Novel Inhibitors of Arachidonic Acid Formation
02/27/2014US20140056972 Anti-dclk1 monoclonal antibodies and methods of production and use thereof
02/27/2014US20140056969 Compositions and methods for sirna inhibition of angiogenesis
02/27/2014US20140056964 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
02/27/2014US20140056951 Methods and compositions for treating biofilms
02/27/2014US20140056950 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
02/27/2014US20140056922 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
02/27/2014US20140056921 Hepatocyte Growth Factor Receptor Antagonists and Uses Thereof
02/27/2014US20140056920 Methods for treating or preventing asthma by administering an il-4r antagonist
02/27/2014US20140056919 Methods and compositions for treating inflammatory conditions
02/27/2014US20140056917 FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death
02/27/2014US20140056916 Aldosterone induced vascular elastin production
02/27/2014US20140056910 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug
02/27/2014US20140056903 Human antibodies to gfr alpha 3 and methods of use thereof
02/27/2014US20140056898 Combination therapies comprising anti-erbb3 agents
02/27/2014US20140056896 Anti-cd19 antibodies and uses in b cell disorders
02/27/2014US20140056891 Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins
02/27/2014US20140056890 Binding Agents That Modulate the Hippo Pathway and Uses Thereof
02/27/2014US20140056889 Compositions and method for treating autoimmune diseases
02/27/2014US20140056888 High concentration antibody formulations
02/27/2014US20140056886 Humanized Anti-IL-20 Antibody And Uses Thereof
02/27/2014US20140056882 Treatment of pulmonary disease conditions
02/27/2014US20140056880 Triazole compounds as ksp inhibitors
02/27/2014US20140056876 Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapy
02/27/2014US20140056875 Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapy
02/27/2014US20140056874 Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapy
02/27/2014US20140056862 Nutritional compositions having alpha-hica and alpha-ketoglutarate
02/27/2014US20140056849 Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
02/27/2014US20140056848 Method for the Treatment of Multiple Sclerosis
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 1151